NCT07677488

Brief Summary

This single-center, prospective, randomized controlled trial aims to evaluate whether an eCASH concept-based analgesia and sedation strategy combined with early goal-directed mobilization can reduce the incidence of intensive care unit-acquired weakness (ICU-AW) in mechanically ventilated ICU patients. A total of 70 adult patients receiving invasive mechanical ventilation will be randomly assigned in a 1:1 ratio to either the intervention group or the control group. The intervention group will receive routine ICU nursing care plus an eCASH-based analgesia and sedation strategy combined with early goal-directed mobilization, while the control group will receive routine ICU nursing care. The primary outcome is the incidence of ICU-AW. Secondary outcomes include total doses of remifentanil and midazolam, respiratory function after extubation, duration of mechanical ventilation, and adverse events.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 23, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 30, 2026

Completed
Last Updated

June 30, 2026

Status Verified

June 1, 2026

Enrollment Period

7 months

First QC Date

June 23, 2026

Last Update Submit

June 28, 2026

Conditions

Keywords

eCASHEarly Goal-Directed MobilizationEarly MobilizationICU-Acquired WeaknessMechanical VentilationIntensive Care UnitAnalgesia and SedationMinimal SedationCritical Care NursingRandomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • Incidence of ICU-Acquired Weakness

    ICU-acquired weakness will be assessed using the Medical Research Council muscle strength score. Six bilateral muscle groups will be evaluated, including shoulder abduction, elbow flexion, wrist extension, hip flexion, knee extension, and ankle dorsiflexion. A total score of less than 48 will be considered diagnostic of ICU-acquired weakness.

    At transfer out of the ICU

Secondary Outcomes (5)

  • Total Dose of Remifentanil

    From enrollment to transfer out of the ICU, assessed up to 6 months

  • Total Dose of Midazolam

    From enrollment to transfer out of the ICU, assessed up to 6 months

  • Forced Vital Capacity After Extubation

    Within 24 hours after extubation

  • Peak Expiratory Flow After Extubation

    Within 24 hours after extubation

  • Duration of Mechanical Ventilation

    From initiation of mechanical ventilation to successful discontinuation, assessed up to 6 months

Study Arms (2)

eCASH Plus Early Goal-Directed Mobilization

EXPERIMENTAL

Participants in this arm will receive routine ICU nursing care plus an eCASH concept-based analgesia and sedation strategy combined with early goal-directed mobilization. The intervention includes comfort-focused care, analgesia-first management, minimal sedation, humanistic care, and individualized progressive mobilization from ICU admission until transfer out of the ICU.

Behavioral: eCASH-Based Analgesia and Sedation Strategy Combined With Early Goal-Directed Mobilization

Routine ICU Nursing Care

ACTIVE COMPARATOR

Participants in this arm will receive routine ICU nursing care, including routine analgesia and sedation management, vital sign monitoring, assessment of consciousness and analgesia/sedation status, muscle strength assessment, airway and tube care, skin care, psychological support, and early activity after clinical stabilization.

Behavioral: Routine ICU Nursing Care

Interventions

This intervention consists of routine ICU nursing care plus an eCASH concept-based analgesia and sedation strategy combined with early goal-directed mobilization. The eCASH strategy includes early combined intervention, promotion of patient comfort, analgesia-first management, minimization of sedative exposure, and humanistic care. Early goal-directed mobilization is individualized according to the patient's clinical condition, functional status, and tolerance, and may include passive or active limb exercises, balance training, bedside cycling exercise, and transcutaneous electrical stimulation.

Also known as: eCASH-EGDM, eCASH Plus Early Mobilization, Early Goal-Directed Mobilization
eCASH Plus Early Goal-Directed Mobilization

Routine ICU nursing care includes routine analgesia and sedation management, monitoring of vital signs, assessment of consciousness and analgesia/sedation status, feedback to the attending physician for medication adjustment, muscle strength assessment, regular turning, sputum suction, airway and tube care, skin care, psychological support, and early activity after clinical stabilization.

Also known as: Conventional ICU Nursing Care, Usual ICU Care
Routine ICU Nursing Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients admitted to the ICU who require invasive mechanical ventilation and have a mechanical ventilation duration of at least 48 hours.
  • Age 18 years or older.
  • Patients who are not undergoing secondary intubation.
  • Patients with relatively stable organ function.
  • Written informed consent provided by the patient's family member or legally authorized representative.

You may not qualify if:

  • Patients in the acute stress phase with hemodynamic instability, including severe patient-ventilator asynchrony, severe traumatic brain injury with intracranial hypertension, status epilepticus, or after cardiopulmonary resuscitation.
  • Patients with severe acute respiratory distress syndrome.
  • Patients with neurological diseases, organic neurological lesions, or neurological injury.
  • Patients with a history of psychiatric disease.
  • Patients with complications causing altered mental status and inability to cooperate, such as hepatic encephalopathy or pulmonary encephalopathy.
  • Patients diagnosed with myasthenia gravis.
  • Patients with a history of psychoactive drug abuse, illicit drug use, or alcohol abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Soochow University

Suzhou, Jiangsu, 215006, China

Location

MeSH Terms

Conditions

Critical IllnessAgnosia

Interventions

Early Ambulation

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors responsible for ICU-acquired weakness diagnosis and respiratory function assessment, as well as statistical analysts, will be blinded to group allocation. Participants and care providers will not be blinded because of the nature of the nursing and mobilization intervention.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Eligible participants will be randomly assigned in a 1:1 ratio to either the intervention group or the control group. The intervention group will receive routine ICU nursing care plus an eCASH concept-based analgesia and sedation strategy combined with early goal-directed mobilization. The control group will receive routine ICU nursing care.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 23, 2026

First Posted

June 30, 2026

Study Start

October 1, 2025

Primary Completion

April 30, 2026

Study Completion

May 1, 2026

Last Updated

June 30, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to patient privacy, ethical restrictions, and institutional data management requirements.

Locations